Biocryst Pharmaceuticals buy Bank of America Co.
Start price
01.07.25
/
50%
€7.65
Target price
01.07.26
€12.73
Performance (%)
13.10%
Price
20.03.26
€8.65
Summary
This prediction is currently active. The prediction currently has a performance of 13.10%. This prediction currently runs until 01.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 19.437% | 19.437% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat